GO:0031550 positive regulation of brain-derived neurotrophic factor receptor signaling pathway: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031550 describes any process that increases the frequency, rate, or extent of signaling through the BDNF receptor, primarily the TrkB receptor.
• BDNF binding to TrkB triggers autophosphorylation and downstream cascades including MAPK, PI3K/Akt, and PLCγ, which are critical for neuronal survival, plasticity, and synaptic function [1, 5].
• Positive regulation of this pathway is implicated in psychiatric disorders, epilepsy, and neurodegenerative conditions, where BDNF-TrkB signaling is often dysregulated [2, 5].
• Psychedelics such as LSD and psilocybin can directly bind TrkB and promote plasticity, highlighting the pathway as a therapeutic target.
• BDNF also regulates retrograde autophagy, axon guidance, and sleep homeostasis through TrkB signaling, demonstrating its broad physiological roles [3, 4, 7].
• Sex steroids and neuroimmune interactions modulate BDNF signaling, adding layers of regulation relevant to disease and therapy [5, 8].
Description
The Gene Ontology term GO:0031550, positive regulation of brain-derived neurotrophic factor receptor signaling pathway, encompasses any process that activates or increases the frequency, rate, or extent of signaling via the BDNF receptor. BDNF is a neurotrophin that binds with high affinity to the tropomyosin receptor kinase B (TrkB), a receptor tyrosine kinase, initiating intracellular signaling cascades essential for neuronal development, survival, and synaptic plasticity [1, 5]. This term is critical for researchers because dysregulation of BDNF-TrkB signaling is linked to a wide range of neurological and psychiatric disorders, including depression, epilepsy, and neurodegenerative diseases [2, 5]. Understanding the positive regulation of this pathway provides insights into potential therapeutic interventions, such as psychedelics that directly activate TrkB. Moreover, BDNF signaling influences diverse processes like retrograde autophagy, axon guidance, and sleep homeostasis, underscoring its broad biological significance [3, 4, 7].
positive regulation of brain-derived neurotrophic factor receptor signaling pathway At A Glance
| GO ID | GO:0031550 |
|---|---|
| GO term | positive regulation of brain-derived neurotrophic factor receptor signaling pathway |
| Ontology | biological_process |
| Synonym | positive regulation of BDNF receptor signaling pathway |
| Major function | Enhances signaling through the BDNF receptor TrkB, promoting neuronal survival, plasticity, and synaptic function [1, 5]. |
| Related receptor | TrkB (NTRK2), a receptor tyrosine kinase. |
| Key ligands | BDNF, and synthetic ligands such as psychedelics. |
| Downstream pathways | MAPK, PI3K/Akt, PLCγ [1, 5]. |
| Disease relevance | Psychiatric disorders, epilepsy, neurodegeneration [2, 5]. |
What Is GO:0031550?
GO:0031550 is defined as any process that activates or increases the frequency, rate, or extent of signaling via the brain-derived neurotrophic factor receptor signaling pathway. In simpler terms, it covers the mechanisms that enhance the transmission of signals from the BDNF receptor (TrkB) into the cell, leading to amplified downstream effects such as neuronal survival, growth, and plasticity [1, 5].
Why Is positive regulation of brain-derived neurotrophic factor receptor signaling pathway Important in Cell Biology?
Positive regulation of BDNF receptor signaling is fundamental for maintaining neuronal health and cognitive function. It is a key node in neuroplasticity, and its enhancement can counteract deficits seen in mood disorders and neurodegenerative diseases [1, 5]. Conversely, excessive or aberrant activation may contribute to epilepsy and other excitability disorders. Thus, understanding how this pathway is positively regulated offers opportunities for therapeutic modulation, as exemplified by psychedelics that directly bind TrkB.
• Critical for neuronal survival and differentiation during development [1, 5].
• Enhances synaptic plasticity, learning, and memory [1, 5].
• Implicated in the pathophysiology of major depressive disorder and anxiety.
• Dysregulation is associated with epilepsy and seizure susceptibility.
• Modulates retrograde autophagy in axons, affecting neuronal homeostasis.
• Regulates axon guidance by counteracting Nogo signaling via LOTUS upregulation.
• Influences sleep homeostasis through TrkB activation in the pedunculopontine tegmental nucleus.
• Interacts with sex steroid signaling, contributing to sex differences in brain function.
• Target of psychedelics for rapid antidepressant effects.
• Potential therapeutic target for neurodegenerative diseases like Alzheimer's.
What Happens During positive regulation of brain-derived neurotrophic factor receptor signaling pathway?
Ligand binding and receptor activation
In simple terms: BDNF or other molecules bind to the TrkB receptor, turning it on.
The pathway begins when BDNF binds to the extracellular domain of TrkB, inducing receptor dimerization and autophosphorylation of intracellular tyrosine residues. This activation can be enhanced by positive regulators such as psychedelics that directly bind TrkB, bypassing the need for BDNF. Additionally, cAMP-mediated secretion of BDNF in developing airway smooth muscle suggests that local BDNF release can amplify signaling.
Downstream signaling cascades
In simple terms: Activated TrkB triggers a series of molecular signals inside the cell.
Phosphorylated TrkB recruits adaptor proteins and activates three major pathways: the MAPK/ERK pathway, the PI3K/Akt pathway, and the PLCγ pathway [1, 5]. These cascades lead to changes in gene expression, protein synthesis, and cellular metabolism that support neuronal survival, growth, and plasticity [1, 5]. Positive regulation can occur at this level through cross-talk with other signaling molecules, such as neuroimmune pathways.
Retrograde transport and autophagy
In simple terms: Signals from the axon terminal are carried back to the cell body, and autophagy is regulated.
BDNF-TrkB signaling at distal axons is internalized and transported retrogradely to the soma, where it influences gene transcription. This retrograde pathway also stimulates axonal autophagy, a process that clears damaged organelles and proteins, contributing to neuronal health. Positive regulation of this pathway can thus enhance retrograde signaling and autophagic flux.
Modulation of axon guidance and plasticity
In simple terms: BDNF signaling helps guide growing axons and adjust synaptic connections.
BDNF induces the expression of lateral olfactory tract usher substance (LOTUS), which antagonizes Nogo signaling and promotes axon growth. This represents a positive regulation of BDNF receptor signaling that counteracts inhibitory cues. Furthermore, TrkB activation in the pedunculopontine tegmental nucleus regulates REM sleep homeostasis, linking BDNF signaling to behavioral plasticity.
Interaction with sex steroids and neuroimmune pathways
In simple terms: Hormones and immune signals can boost or dampen BDNF signaling.
Sex steroids such as estrogen and testosterone modulate BDNF expression and TrkB signaling, contributing to sex differences in brain function and disease susceptibility. Additionally, neuroimmune pathways interact with BDNF signaling, and alterations in these interactions are implicated in major psychiatric disorders. Positive regulation can therefore be influenced by hormonal and immune status [5, 8].
Key Genes Involved in GO:0031550 positive regulation of brain-derived neurotrophic factor receptor signaling pathway
The following genes and proteins are central to the positive regulation of BDNF receptor signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BDNF | Primary ligand for TrkB; activates signaling | Therapeutic target; biomarker in psychiatric disorders |
| NTRK2 (TrkB) | Receptor tyrosine kinase; mediates BDNF effects | Target of psychedelics; mutations linked to mood disorders [1, 5] |
| LOTUS | Upregulated by BDNF; antagonizes Nogo signaling | Promotes axon regeneration; potential target for spinal cord injury |
| CREB | Transcription factor activated downstream of TrkB; regulates gene expression | Key mediator of plasticity and survival |
| MAPK1/3 (ERK1/2) | Kinases in MAPK cascade; promote neuronal differentiation | Involved in learning and memory; drug targets |
| PIK3CA | Catalytic subunit of PI3K; activates Akt pathway | Cell survival signaling; cancer and neuroprotection |
| AKT1 | Serine/threonine kinase; promotes cell survival | Dysregulated in neurodegeneration and cancer |
| PLCG1 | Phospholipase C gamma; generates IP3 and DAG | Modulates calcium signaling and synaptic plasticity |
| NGF | Neurotrophin with overlapping functions; can modulate TrkA | Comparative studies with BDNF |
| NGFR (p75) | Low-affinity neurotrophin receptor; modulates Trk signaling | Apoptosis and survival balance |
| SORT1 | Sortilin; facilitates BDNF secretion and trafficking | Regulates BDNF availability |
| CAMK2A | Calcium/calmodulin-dependent kinase; downstream of TrkB | Synaptic plasticity and sleep regulation |
| ARC | Activity-regulated cytoskeleton-associated protein; induced by BDNF | Immediate early gene; marker of plasticity |
| GABRA1 | GABA receptor subunit; modulated by BDNF | Epilepsy and inhibitory signaling |
| GRIN2B | NMDA receptor subunit; interacts with BDNF signaling | Epilepsy and excitotoxicity |
| ESR1 | Estrogen receptor alpha; modulates BDNF expression | Sex differences in mood disorders |
| AR | Androgen receptor; interacts with BDNF signaling | Neuroprotection and gender-specific effects |
| TNF | Pro-inflammatory cytokine; influences BDNF signaling | Neuroinflammation in psychiatric disorders |
How Is positive regulation of brain-derived neurotrophic factor receptor signaling pathway Regulated?
Positive regulation of BDNF receptor signaling is controlled at multiple levels. Ligand availability is regulated by BDNF secretion, which can be enhanced by cAMP signaling. Receptor sensitivity can be modulated by TrkB phosphorylation and trafficking, as well as by interactions with p75 and sortilin. Downstream, feedback loops involving phosphatases and ubiquitin ligases fine-tune the intensity and duration of signaling. Additionally, sex steroids and neuroimmune cytokines can upregulate or downregulate pathway components, providing systemic regulation [5, 8]. Psychedelics represent exogenous positive regulators that directly bind TrkB and enhance signaling.
positive regulation of brain-derived neurotrophic factor receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BDNF | Depression, anxiety | BDNF knockout mice; chronic stress models |
| NTRK2 | Mood disorders, epilepsy [1, 2] | TrkB conditional knockout; point mutation knock-in [1, 2] |
| LOTUS | Axonal regeneration failure | LOTUS overexpression in neuronal cultures |
| ESR1 | Sex differences in depression | Estrogen receptor knockout mice |
| TNF | Neuroinflammation in psychiatric disorders | TNF transgenic mice; cytokine challenge |
Psychiatric disorders
Alterations in BDNF-TrkB signaling are consistently observed in major depressive disorder, bipolar disorder, and schizophrenia. Positive regulation of this pathway may underlie the rapid antidepressant effects of psychedelics, which directly activate TrkB. Neuroimmune interactions further modulate these effects, suggesting that boosting BDNF signaling could be therapeutic.
Epilepsy
BDNF signaling is upregulated in epileptic foci and contributes to hyperexcitability and seizure generation. Positive regulation of TrkB signaling may exacerbate seizures, while inhibition could be protective. However, the pathway also supports neuronal survival, so therapeutic modulation requires careful balance.
Neurodegenerative diseases
Reduced BDNF-TrkB signaling is implicated in Alzheimer's and Parkinson's diseases, where it contributes to neuronal loss. Enhancing this pathway through positive regulators, such as small molecules or gene therapy, is a potential therapeutic strategy [1, 5]. Retrograde autophagy defects linked to BDNF signaling may also contribute to neurodegeneration.
Axonal injury and regeneration
BDNF-induced LOTUS expression counteracts Nogo signaling, promoting axon regeneration after injury. Thus, positive regulation of BDNF receptor signaling may aid recovery from spinal cord injury and other axonopathies.
From positive regulation of brain-derived neurotrophic factor receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate BDNF signaling? | CRISPR knockout of gene X in primary neurons, followed by BDNF stimulation and phospho-TrkB measurement |
| Does a point mutation in TrkB alter downstream signaling? | Knock-in mice or cell lines carrying the mutation |
| Can a drug enhance BDNF signaling? | Overexpression of TrkB in cell lines, treated with candidate compounds |
| What is the role of BDNF retrograde transport? | Tagged knock-in of BDNF or TrkB with fluorescent proteins for live imaging |
| How does BDNF signaling affect sleep? | Conditional knockout of TrkB in pedunculopontine tegmental nucleus in mice |
| Does LOTUS mediate BDNF effects on axon growth? | LOTUS knockout and overexpression in neuronal cultures |
How to Study the positive regulation of brain-derived neurotrophic factor receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Protein phosphorylation levels | Assess TrkB activation after BDNF stimulation |
| Immunoprecipitation | Protein-protein interactions | Identify TrkB binding partners |
| Live-cell imaging | Receptor trafficking and retrograde transport | Study BDNF-TrkB endocytosis |
| RNA-seq | Transcriptional changes | Identify downstream target genes |
| Phosphoproteomics | Global phosphorylation events | Map signaling networks |
| Behavioral tests | Cognitive and sleep phenotypes | Evaluate functional outcomes in mice |
| CRISPR screening | Identify positive regulators | Genome-wide knockout screens for modulators of BDNF signaling |
| Proximity ligation assay | In situ protein interactions | Visualize TrkB interactions in tissue |
Phospho-proteomics and Western blotting
To assess positive regulation, researchers measure phosphorylation of TrkB and downstream effectors like ERK and Akt using phospho-specific antibodies. Quantitative Western blotting or mass spectrometry-based phosphoproteomics can reveal changes in signaling intensity upon genetic or pharmacological manipulation.
Live-cell imaging and retrograde transport assays
Fluorescently tagged BDNF or TrkB allows visualization of receptor internalization and retrograde transport in neurons. Time-lapse imaging can quantify the efficiency of retrograde signaling, a key aspect of positive regulation.
Transcriptomics and RNA-seq
RNA sequencing after BDNF stimulation identifies gene expression changes driven by TrkB signaling. This method can uncover feedback regulators and downstream targets that contribute to positive regulation.
Behavioral assays in animal models
Tests for learning, memory, anxiety, and sleep in mice with genetic modifications of BDNF signaling components provide functional evidence of positive regulation [7, 8]. For example, TrkB activation in the pedunculopontine tegmental nucleus affects REM sleep.
How CRISPR Can Be Used to Study GO:0031550 positive regulation of brain-derived neurotrophic factor receptor signaling pathway
Knockout
CRISPR knockout of candidate genes can determine whether they are required for positive regulation of BDNF receptor signaling. For example, knocking out NTRK2 abolishes BDNF signaling, while knocking out negative regulators may enhance it. Pooled knockout screens can identify novel modulators.
Point Mutation
Introducing point mutations in TrkB or downstream effectors via CRISPR can mimic disease-associated variants or test specific phosphorylation sites. For instance, mutation of TrkB autophosphorylation sites can reveal their role in positive regulation.
Knock-in
Knock-in of fluorescent tags or epitope tags into endogenous loci allows tracking of BDNF or TrkB trafficking and interactions. This is useful for studying retrograde transport and receptor dynamics.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can boost BDNF or TrkB levels to study positive regulation. Overexpression of LOTUS, for example, enhances BDNF effects on axon growth.
How EDITGENE Supports positive regulation of brain-derived neurotrophic factor receptor signaling pathway Research
Researchers studying positive regulation of brain-derived neurotrophic factor receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in enhancing BDNF-TrkB signaling. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides these services to accelerate discovery in neurobiology and therapeutic development.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of brain-derived neurotrophic factor receptor signaling pathway research.
Frequently Asked Questions About positive regulation of brain-derived neurotrophic factor receptor signaling pathway
What is GO:0031550?
GO:0031550 is a Gene Ontology term for any process that activates or increases the frequency, rate, or extent of signaling via the brain-derived neurotrophic factor receptor signaling pathway.
What genes are involved in positive regulation of BDNF receptor signaling?
Key genes include BDNF, NTRK2 (TrkB), LOTUS, CREB, MAPK1/3, PIK3CA, AKT1, and PLCG1, among others [1, 4, 5].
How is BDNF receptor signaling positively regulated?
It can be enhanced by ligand binding (BDNF or psychedelics), receptor phosphorylation, downstream cross-talk, and modulation by hormones or immune signals [1, 5, 8].
What diseases are associated with BDNF receptor signaling?
Psychiatric disorders, epilepsy, neurodegenerative diseases, and axonal injury are linked to dysregulation of this pathway [2, 4, 5].
What is the role of TrkB in BDNF signaling?
TrkB is the high-affinity receptor for BDNF; its activation triggers MAPK, PI3K/Akt, and PLCγ cascades that promote neuronal survival and plasticity.
Can psychedelics enhance BDNF signaling?
Yes, psychedelics like LSD and psilocybin directly bind TrkB and promote plasticity, acting as positive regulators.
How does BDNF affect autophagy?
BDNF stimulates retrograde autophagy in axons, helping clear damaged components and maintain neuronal health.
What is LOTUS and its connection to BDNF?
LOTUS is upregulated by BDNF and antagonizes Nogo signaling, promoting axon growth.
Does BDNF signaling affect sleep?
Yes, TrkB activation in the pedunculopontine tegmental nucleus regulates REM sleep homeostasis.
How can CRISPR be used to study BDNF receptor signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of pathway components to test their roles in positive regulation [1, 3, 4].
Conclusion
GO:0031550, positive regulation of brain-derived neurotrophic factor receptor signaling pathway, is a critical biological process that amplifies BDNF-TrkB signaling to support neuronal survival, plasticity, and diverse physiological functions [1, 5]. Its dysregulation is implicated in psychiatric, neurological, and neurodegenerative disorders, making it a prime therapeutic target [2, 5]. Advances in CRISPR-based models and screening technologies are accelerating the discovery of novel regulators and drug candidates. EDITGENE offers comprehensive services to facilitate this research, from knockout to overexpression and bioinformatics.
References
- 1. Moliner R et al.. 2023. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.. Nat Neurosci 26(6):1032-1041 PMID: 37280397
- 2. AlRuwaili R et al.. 2024. The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy.. Neurochem Res 49(3):533-547 PMID: 38006577
- 3. Sidibe DK et al.. 2022. Brain-derived neurotrophic factor stimulates the retrograde pathway for axonal autophagy.. J Biol Chem 298(12):102673 PMID: 36336077
- 4. Matsubayashi J et al.. 2023. Brain-derived neurotrophic factor (BDNF) induces antagonistic action to Nogo signaling by the upregulation of lateral olfactory tract usher substance (LOTUS) expression.. J Neurochem 164(1):29-43 PMID: 36448220
- 5. Mehterov N et al.. 2022. Interactions Among Brain-Derived Neurotrophic Factor and Neuroimmune Pathways Are Key Components of the Major Psychiatric Disorders.. Mol Neurobiol 59(8):4926-4952 PMID: 35657457
- 6. Thompson MA et al.. 2015. cAMP-mediated secretion of brain-derived neurotrophic factor in developing airway smooth muscle.. Biochim Biophys Acta 1853(10 Pt A):2506-14 PMID: 26112987
- 7. Barnes AK et al.. 2017. Activation of brain-derived neurotrophic factor-tropomyosin receptor kinase B signaling in the pedunculopontine tegmental nucleus: a novel mechanism for the homeostatic regulation of rapid eye movement sleep.. J Neurochem 141(1):111-123 PMID: 28027399
- 8. de Assis GG et al.. 2025. Sex Steroids and Brain-Derived Neurotrophic Factor Interactions in the Nervous System: A Comprehensive Review of Scientific Data.. Int J Mol Sci 26(6) PMID: 40141172
